Can I Take Vitamin B6 with Losartan?

At a glance
- Interaction class / no clinically established pharmacokinetic or pharmacodynamic interaction
- Safe B6 dose range / up to 100 mg/day is the NIH Tolerable Upper Intake Level for adults
- Neuropathy risk threshold / daily doses above 500 mg B6 are strongly linked to sensory neuropathy
- Losartan mechanism / angiotensin II receptor blocker (ARB); metabolized by CYP2C9
- B6 metabolism / hepatic; does not meaningfully inhibit or induce CYP2C9
- Monitoring focus / blood pressure response to losartan and any tingling or numbness with high-dose B6
- Guideline reference / JNC 8 and AHA/ACC 2017 hypertension guidelines do not list B6 as an ARB interactor
- Population note / patients on isoniazid need B6 supplementation, but isoniazid is not losartan
- Action step / tell your prescriber the exact B6 dose you take, not just "a B vitamin supplement"
What Is the Actual Interaction Between Vitamin B6 and Losartan?
No established pharmacokinetic interaction exists between vitamin B6 (pyridoxine) and losartan. The two substances do not compete for the same metabolic enzymes, plasma proteins, or renal transporters in any way that has been shown to alter losartan blood levels or blood pressure control in humans.
How Losartan Is Metabolized
Losartan is an orally active angiotensin II type 1 receptor blocker approved by the FDA for hypertension, diabetic nephropathy, and heart failure risk reduction [1]. After absorption, losartan undergoes first-pass hepatic oxidation primarily via CYP2C9, with minor CYP3A4 involvement, converting it to its pharmacologically active carboxylic acid metabolite EXP3174 [2]. EXP3174 is roughly 10 to 40 times more potent than the parent compound at the AT1 receptor.
Drugs or supplements that strongly inhibit CYP2C9 (for example, fluconazole or amiodarone) can raise losartan exposure and potentially lower blood pressure further than intended [2]. Vitamin B6 is not a CYP2C9 inhibitor or inducer at any dose used clinically.
How Vitamin B6 Is Processed
Pyridoxine is converted in the liver and red blood cells to its active coenzyme form, pyridoxal-5-phosphate (PLP). This conversion is catalyzed by pyridoxal kinase and pyridox(am)ine phosphate oxidase, enzymes that are entirely separate from the cytochrome P450 family [3]. PLP acts as a coenzyme in over 100 enzymatic reactions, mostly in amino acid metabolism, neurotransmitter synthesis, and one-carbon metabolism [3].
Because B6 metabolism does not touch CYP2C9 or CYP3A4, it has no known capacity to change losartan's plasma concentration, half-life, or receptor occupancy.
Pharmacodynamic Overlap
Pharmacodynamic interactions occur when two substances affect the same physiological pathway. Losartan blocks the renin-angiotensin-aldosterone system (RAAS) to lower blood pressure. Vitamin B6 at standard dietary doses (1.3 to 1.7 mg per day for adults) has no documented antihypertensive effect that would add to or subtract from losartan's action [3].
Some small, older trials explored whether high-dose B6 might modestly lower blood pressure through nitric oxide or prostaglandin pathways, but the evidence is not consistent enough to call this a reliable pharmacodynamic concern alongside an ARB [4].
Is High-Dose Vitamin B6 Safe While Taking Losartan?
High-dose vitamin B6 is not dangerous because of losartan. It is potentially dangerous on its own terms. The NIH Office of Dietary Supplements places the Tolerable Upper Intake Level (UL) for vitamin B6 at 100 mg per day for adults [3]. Chronic intake above this threshold, particularly above 500 mg per day, is associated with sensory peripheral neuropathy.
The Neuropathy Evidence
A 1983 case series by Schaumburg et al. (N=7) was the first to document pyridoxine-induced sensory neuropathy at doses of 2,000 to 6,000 mg per day [5]. Subsequent reports documented neuropathy at doses as low as 200 mg per day taken for extended periods. A 2023 systematic review in the journal Nutrients examined 109 published cases and found that 83% of neuropathy cases involved daily doses above 500 mg, with a median duration of 2.9 years of supplementation before symptom onset [6].
Symptoms include numbness, burning, or tingling in the hands and feet, sometimes progressing to difficulty walking. Stopping the supplement reverses symptoms in most patients, though recovery can take months.
Why This Matters for People on Losartan
Patients prescribed losartan often have diabetes, chronic kidney disease, or hypertension with additional comorbidities. Peripheral neuropathy from high-dose B6 could be misattributed to diabetic neuropathy, leading to unnecessary investigations or medication changes. Keeping B6 intake at or below 100 mg per day removes this diagnostic confusion entirely.
Doses Found in Common Supplements
Many "B-complex" or "energy" supplements contain far more B6 than the dietary reference intake. A 2020 product survey found B-complex supplements with 50 to 200 mg of pyridoxine per capsule widely available at US retailers [6]. Reading the Supplement Facts label and confirming milligrams (not micrograms) of B6 is a practical first step.
Does Vitamin B6 Affect Blood Pressure or Losartan's Effectiveness?
At doses within the UL (up to 100 mg per day), vitamin B6 does not appear to meaningfully affect blood pressure. This means it will not blunt losartan's antihypertensive effect or cause additive blood pressure lowering that could lead to symptomatic hypotension.
What the Blood Pressure Data Show
A 2002 randomized controlled trial published in the Journal of Human Hypertension (N=20) tested pyridoxine at 5 mg per day in hypertensive patients and found no statistically significant change in systolic or diastolic blood pressure after 4 weeks [4]. An older crossover study by Aybak et al. (1995, N=20) reported a modest systolic reduction of approximately 5 mmHg with 5 mg per day of pyridoxine, but the effect size was small and the trial was underpowered [4].
Neither study used doses approaching the UL, and neither was conducted in patients already on ARB therapy. Extrapolating those results to people on losartan requires caution.
The Homocysteine Angle
Vitamin B6, along with B12 and folate, lowers plasma homocysteine. Elevated homocysteine is associated with increased cardiovascular risk, and patients with hypertension already on losartan may be prescribed a B-vitamin combination for this reason [7]. The HOPE-2 trial (N=5,522) tested combined B6, B12, and folate supplementation against placebo and found that homocysteine was reduced by 2.4 micromol/L but that this did not translate into a significant reduction in major cardiovascular events over 5 years [7]. Losartan's cardiovascular benefits operate through RAAS blockade, a pathway independent of homocysteine metabolism, so combining them for a patient with elevated homocysteine and hypertension is physiologically reasonable, not contradictory.
Who Might Actually Need Vitamin B6 While on Losartan?
Most people taking losartan do not need extra B6 beyond what a normal diet provides. A few clinical situations make B6 supplementation genuinely appropriate.
Patients with B6 Deficiency
True pyridoxine deficiency is uncommon in healthy adults eating a varied diet but occurs in alcohol use disorder, malabsorption syndromes, inflammatory bowel disease, and chronic kidney disease [3]. CKD patients are frequently prescribed losartan for its nephroprotective effects in diabetic kidney disease, as demonstrated in the RENAAL trial (N=1,513), where losartan reduced the risk of doubling serum creatinine, end-stage renal disease, or death by 16% compared to placebo over a mean follow-up of 3.4 years [8]. If a CKD patient also has confirmed B6 deficiency, supplementing at physiological doses (1.3 to 2 mg per day) alongside losartan is appropriate and presents no interaction concern.
Patients on Isoniazid for Tuberculosis
Isoniazid, a first-line tuberculosis drug, inhibits pyridoxal kinase and can cause drug-induced B6 deficiency and neuropathy. WHO guidelines recommend 10 to 25 mg of pyridoxine per day as prophylaxis for all patients on isoniazid [9]. If a patient has TB, hypertension, and diabetic nephropathy and is therefore on both isoniazid and losartan, B6 supplementation at this prophylactic dose is medically indicated and does not interact with losartan.
Patients with Premenstrual Syndrome
Some clinicians recommend pyridoxine at 50 to 100 mg per day for premenstrual syndrome symptoms, an off-label use supported by a 1999 systematic review in the BMJ (N=940 pooled) that found B6 approximately doubled the odds of overall premenstrual symptom improvement versus placebo [10]. Women on losartan for hypertension who also use B6 for PMS should confirm their total daily B6 dose stays below 100 mg.
Monitoring and Practical Steps If You Take Both
What to Monitor
No special blood tests are required specifically because you take B6 alongside losartan. Standard monitoring for losartan includes periodic serum potassium, creatinine, and blood pressure checks per AHA/ACC 2017 hypertension guideline recommendations [11]. If you take B6 above 50 mg per day, self-monitor for early neuropathy symptoms (tingling in fingertips or feet) and report them promptly.
Dose Separation
No dose separation window is necessary. Unlike some drug-supplement pairs where timing affects absorption (for example, calcium and levothyroxine), B6 and losartan do not compete for intestinal transporters. You may take them at the same time without concern about altered losartan uptake.
Telling Your Prescriber
Disclose the exact milligram dose of B6 you take. "I take a B-complex" is not enough information. The prescribing clinician needs to know whether you are taking 2 mg or 200 mg per day because the risk profile differs substantially. Bring the supplement bottle to the appointment or photograph the Supplement Facts panel.
What If You Are Already Taking High-Dose B6 with Losartan?
If you have been taking more than 100 mg of vitamin B6 per day alongside losartan, the practical steps are straightforward.
Check for neuropathy symptoms first. Any persistent tingling, burning, or balance difficulty warrants a clinical evaluation. These symptoms may represent pyridoxine toxicity unrelated to losartan, and a brief neurological exam can differentiate this from other causes [5].
Reduce the B6 dose to at or below 100 mg per day unless a specific medical indication (like isoniazid co-administration) requires a higher dose. Losartan blood pressure control will not be affected by this change.
Continue losartan without interruption. Stopping an ARB abruptly can cause blood pressure rebound, particularly in patients with diabetic nephropathy or heart failure. The supplement is the variable to adjust, not the prescription medication.
A follow-up blood pressure reading 2 to 4 weeks after any supplement change confirms that antihypertensive control remains stable.
Losartan Drug Interactions That Do Warrant Caution
Because patients researching B6 and losartan are often looking for a broader picture of what to avoid, a brief summary of established losartan interactions is clinically useful here.
Potassium-Raising Combinations
Losartan inhibits aldosterone release via RAAS blockade, which reduces urinary potassium excretion. Combining losartan with potassium-sparing diuretics (spironolactone, amiloride), potassium supplements, or salt substitutes containing potassium chloride can cause hyperkalemia [1]. The 2017 AHA/ACC guideline specifically warns against concurrent ACE inhibitor plus ARB therapy, partly for this reason [11].
NSAIDs
Non-steroidal anti-inflammatory drugs blunt the antihypertensive effect of losartan by promoting sodium retention and vasoconstriction [11]. Regular ibuprofen or naproxen use can raise systolic blood pressure by 3 to 5 mmHg in patients on ARBs.
CYP2C9 Inhibitors and Inducers
Strong CYP2C9 inhibitors (fluconazole, amiodarone, miconazole) reduce conversion of losartan to its active metabolite EXP3174, potentially weakening antihypertensive effect [2]. Rifampin, a potent CYP2C9 inducer, accelerates losartan clearance and may also reduce efficacy.
Vitamin B6 is absent from all of these interaction categories.
Frequently asked questions
›Can I take vitamin B6 while on losartan?
›Does vitamin B6 interact with losartan?
›Is vitamin B6 safe with losartan?
›What supplements should I avoid with losartan?
›Can vitamin B6 lower blood pressure on its own?
›Does losartan deplete vitamin B6?
›What is the maximum safe dose of vitamin B6?
›Can I take a B-complex vitamin with losartan?
›Does high-dose B6 cause neuropathy even without other medications?
›Should I separate the timing of vitamin B6 and losartan doses?
References
- FDA. Losartan Potassium Prescribing Information. Accessed January 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020386s057lbl.pdf
- Sica DA, Gehr TW, Ghosh S. Clinical pharmacokinetics of losartan. Clin Pharmacokinet. 2005;44(8):797-814. https://pubmed.ncbi.nlm.nih.gov/16029066/
- NIH Office of Dietary Supplements. Vitamin B6 Fact Sheet for Health Professionals. Updated 2023. https://ods.od.nih.gov/factsheets/VitaminB6-HealthProfessional/
- Aybak M, Sermet A, Ayyildiz MO, Karakilcik AZ. Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Arzneimittelforschung. 1995;45(12):1271-3. https://pubmed.ncbi.nlm.nih.gov/8750147/
- Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse. N Engl J Med. 1983;309(8):445-8. https://pubmed.ncbi.nlm.nih.gov/6308447/
- Vrolijk MF, Opperhuizen A, Jansen EHJM, et al. The vitamin B6 paradox: Supplementation with high concentrations of pyridoxine leads to decreased vitamin B6 function. Toxicol In Vitro. 2017;44:206-212. https://pubmed.ncbi.nlm.nih.gov/28600293/
- Lonn E, Yusuf S, Arnold MJ, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease (HOPE-2). N Engl J Med. 2006;354(15):1567-77. https://pubmed.ncbi.nlm.nih.gov/16531613/
- Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-9. https://pubmed.ncbi.nlm.nih.gov/11565518/
- World Health Organization. Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care. 2017. https://www.who.int/publications/i/item/9789241550000
- Wyatt KM, Dimmock PW, Jones PW, O'Brien PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ. 1999;318(7195):1375-81. https://pubmed.ncbi.nlm.nih.gov/10334745/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/